Serious issues on the bonus scheme setting long term metrics 2019 at $1 dollar SP and "Raw" earnings at $70 million, which I assume is EBIT. Board defence that the metrics were set at the time SP was 50 cents is pathetic. That was an artificially low price brought about by cap raising.
Raw earnings now forcast At $112 million and SP is 95 Cents. How does this align with shareholder interests or even Crescents?
- Forums
- ASX - By Stock
- CDD
- Ann: Results of Meeting-CDD.AX
Ann: Results of Meeting-CDD.AX, page-2
Featured News
Add CDD (ASX) to my watchlist
(20min delay)
|
|||||
Last
24.5¢ |
Change
0.060(32.4%) |
Mkt cap ! $13.28M |
Open | High | Low | Value | Volume |
19.0¢ | 24.5¢ | 19.0¢ | $52.44K | 271.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 444 | 24.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
30.0¢ | 10 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 14017 | 1.060 |
1 | 14492 | 1.035 |
1 | 15000 | 1.030 |
1 | 33300 | 1.025 |
1 | 24875 | 1.005 |
Price($) | Vol. | No. |
---|---|---|
1.080 | 14424 | 2 |
1.095 | 1729 | 1 |
1.125 | 9538 | 1 |
1.140 | 5000 | 1 |
1.150 | 10949 | 1 |
Last trade - 16.10pm 25/11/2024 (20 minute delay) ? |
Featured News
CDD (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online